MODERNA said on Friday it has filed a marketing application for the review of its updated Covid-19 vaccine with the US Food and Drug Administration (FDA).

Experts believe the rise in the COVID-19 cases in South Asia is due to the JN.1 variant, a sub-variant of Omicron.

Over 50% of Africa’s generics, nearly 47% of the US’s generic demand, and approximately 25% of the UK’s medicine needs are ...